Back to Search
CORY BOWERS, PHARMD
PHARMD
Pharmacist
NPI: 1124652771Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
18863-40(WI)
Research & Publications (20)
Aromatase and 5alpha-reductase inhibition during an exogenous testosterone clamp unveils selective sex steroid modulation of somatostatin and growth hormone secretagogue actions in healthy older men.
PMID 19088159·J Clin Endocrinol Metab·2009
2-rct
Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism.
PMID 19458139·Eur J Endocrinol·2009
2-rct
Relative effects of estrogen, age, and visceral fat on pulsatile growth hormone secretion in healthy women.
PMID 19470834·Am J Physiol Endocrinol Metab·2009
2-rct
Local and collective motions in precise polyolefins with alkyl branches: a combination of 2H and 13C solid-state NMR spectroscopy.
PMID 19437520·Angew Chem Int Ed Engl·2009
8-other
Determinants of GH-releasing hormone and GH-releasing peptide synergy in men.
PMID 19240251·Am J Physiol Endocrinol Metab·2009
2-rct
The effect of growth hormone releasing peptide-2 on upper gastrointestinal contractile activity and food intake in conscious dogs.
PMID 19271111·J Gastroenterol·2009
7-preclinical
Traditional ankle arthrodesis for the treatment of ankle arthritis.
PMID 19389598·Clin Podiatr Med Surg·2009
6-review
Factors other than sex steroids modulate GHRH and GHRP-2 efficacies in men: evaluation using a GnRH agonist/testosterone clamp.
PMID 19351731·J Clin Endocrinol Metab·2009
2-rct
Novel relationships of age, visceral adiposity, insulin-like growth factor (IGF)-I and IGF binding protein concentrations to growth hormone (GH) releasing-hormone and GH releasing-peptide efficacies in men during experimental hypogonadal clamp.
PMID 19351723·J Clin Endocrinol Metab·2009
2-rct
Twenty-four hour continuous ghrelin infusion augments physiologically pulsatile, nycthemeral, and entropic (feedback-regulated) modes of growth hormone secretion.
PMID 18593763·J Clin Endocrinol Metab·2008
3-trial
Growth hormone releasing peptide 2 reverses anorexia associated with chemotherapy with 5-fluoruracil in colon cancer cell-bearing mice.
PMID 19009643·World J Gastroenterol·2008
7-preclinical
Estrogen elevates the peak overnight production rate of acylated ghrelin.
PMID 18697865·J Clin Endocrinol Metab·2008
2-rct
Pituitary and/or peripheral estrogen-receptor alpha regulates follicle-stimulating hormone secretion, whereas central estrogenic pathways direct growth hormone and prolactin secretion in postmenopausal women.
PMID 18089703·J Clin Endocrinol Metab·2008
2-rct
Validation of growth-hormone-releasing peptide 2 for the diagnosis of adult growth hormone deficiency.
PMID 17971793·Nat Clin Pract Endocrinol Metab·2008
8-other
Gonadal status and body mass index jointly determine growth hormone (GH)-releasing hormone/GH-releasing peptide synergy in healthy men.
PMID 18073313·J Clin Endocrinol Metab·2008
2-rct
A structural equation modeling approach to the study of stress and psychological adjustment in emerging adults.
PMID 18449637·Child Psychiatry Hum Dev·2008
8-other
32P as an adjunct to standard therapy for locally advanced unresectable pancreatic cancer: a randomized trial.
PMID 18266048·J Gastrointest Surg·2008
2-rct
Dramatic enhancement of hyperpolarized xenon-129 2D-NMR exchange cross-peak signals in nanotubes by interruption of the gas flow.
PMID 18237170·J Am Chem Soc·2008
8-other
Estrogen supplementation selectively enhances hypothalamo-pituitary sensitivity to ghrelin in postmenopausal women.
PMID 18611978·J Clin Endocrinol Metab·2008
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 15350 W BLUEMOUND RD
ELM GROVE, WI 53122 - Phone
- (262) 789-6819
Quick Facts
- NPI
- 1124652771
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile